Jazz Pharmaceuticals plc

Ownership Transactions Reported by 27 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+12K	41.3%	$119.65	+$1.44M
Sells	4	-17K	58.7%	$115.88	-$1.97M
Net	-3	-5.03K	-17.3%		-$538K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Seamus Mulligan	Director	$128M			Aug 2, 2024
Bruce C. Cozadd	Chairman & CEO, Director	$51.7M	-$353K	-0.68%	Dec 2, 2024
Robert Iannone	EVP, Global Head of R&D	$7.31M			Mar 5, 2024
Renee D. Gala	President & COO	$6.85M			Dec 5, 2024
Daniel N. Swisher JR	President and COO	$6.55M			Mar 3, 2023
Neena M. Patil	EVP & Chief Legal Officer	$4.08M	-$1M	-19.8%	Nov 8, 2024
Kenneth O'Keefe	Director	$3.5M			Aug 2, 2024
Kim Sablich	EVP, GM of U.S.	$3.39M			Jun 5, 2023
Philip L. Johnson	EVP & Chief Financial Officer	$3.34M	+$1.44M	+75.3%	Mar 1, 2024
Patrick G. Enright	Director	$2.75M			Aug 2, 2024
Samantha Pearce	EVP, Chief Commercial Officer	$2.62M			Aug 2, 2024
Finbar Larkin	SVP, Technical Operations	$2.59M			Mar 3, 2023
Heather McSharry	Director	$2.1M			Aug 2, 2024
Peter Gray	Director	$1.91M			Aug 11, 2023
Norbert Riedel	Director	$1.78M			Aug 2, 2024
Catherine A. Sohn	Director	$1.77M			Aug 11, 2023
Christopher J. Tovey	EVP, COO & Managing Director E	$1.75M			Jul 5, 2022
Anne ORiordan	Director	$1.65M			Aug 2, 2024
Mary Elizabeth Henderson	SVP, Technical Operations	$1.57M	-$153K	-8.85%	Sep 6, 2024
Rick E. Winningham	Director	$1.41M			Aug 2, 2024
Jennifer Cook	Director	$1.02M			Aug 2, 2024
Mark Douglas Smith	Director	$1.02M			Aug 2, 2024
Paul L. Berns	Director	$988K			Aug 5, 2021
Elmar Schnee	Director	$985K			Aug 5, 2021
Patricia Carr	SVP, Chief Accounting Officer	$808K	-$463K	-36.4%	Dec 2, 2024
Laura Hamill	Director	$569K			Aug 2, 2024
Patrick Kennedy	Director	$561K			Aug 2, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.